TP53 and cancer: On the one hand, emerging evidence suggests that oncogenes and tumor suppressor genes in cancer, which usually include MYC, HIF, P53, and RAS, regulate the metabolic phenotype of tumor cells and inhibit the TCA cycle, diverting glutamine to fuel the TCA cycle (Anderson et al., 2018).